Leading biotech innovators & startups shine at Global Bio-India 2023 Awards biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
Hester Biosciences to produce Bharat Biotech s Covaxin
The MoU stated that Hester will provide complete infrastructure to manufacture the indigenously developed anti-COVID vaccine
BusinessToday.In | May 28, 2021 | Updated 12:06 IST
Ahmedabad-based Hester Biosciences will produce 20 million doses of Bharat Biotech s COVID-19 vaccine Covaxin per month from August 2021. A memorandum of understanding (MoU) has been inked between the Hyderabad-based pharma giant Bharat Biotech and Gujarat COVID Vaccine Consortium (GCVC) regarding the same.
GCVC comprises Gujarat Biotechnology Research Centre (GBRC), Hester Biosciences and Omnibrx Biotechnologies, Hester stated in a regulatory filing.
Bharat Biotech will provide production technology of the drug substance for Covaxin and GBRC will act as an advisor, mentor, and shall facilitate technology transfer from Bharat Biotech, as per this MoU. The MoU added Hester will provide complete infrastructure to manufacture the indigenously develope
Read more about Hester Biosciences soars after GCVC inks MoU with Bharat Biotech on Business Standard. Hester Biosciences surged 9.66% to Rs 2980 after Gujarat Covid Vaccine Consortium (GCVC) signed a pact with Bharat Biotech International towards contract manufacturing for the drug substance for Covaxin.
Hester Biosciences to produce Bharat Biotech s Covaxin businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.